SLAMF1 Promotes Methotrexate Resistance via Activating Autophagy in Choriocarcinoma Cells

OBJECTIVE: The acquisition of chemoresistance to methotrexate (MTX) still remains one of the major challenges for choriocarcinoma treatment. Herein, we aimed to evaluate the potential role of Signaling Lymphocytic Activation Molecule Family Member 1 (SLAMF1) as a possible regulator of chemoresistanc...

Descripción completa

Detalles Bibliográficos
Autores principales: Shi, Dazun, Zhang, Yu, Tian, Yan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7779304/
https://www.ncbi.nlm.nih.gov/pubmed/33408515
http://dx.doi.org/10.2147/CMAR.S278012

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7779304/
https://www.ncbi.nlm.nih.gov/pubmed/33408515
http://dx.doi.org/10.2147/CMAR.S278012

Ejemplares similares